Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (661-670 of 842) with videos related to

Pageof 85
Sort By:
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 24, 2017
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF TrialStephen J Greene, Adrian F Hernandez, Allison Dunning, et al.
Circulation. Heart Failure|September 15, 2016
Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Stephen J Greene, Adrian F Hernandez, Jie-Lena Sun, et al.
Circulation. Heart Failure|March 3, 2022
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HFGregory D Lewis, Kieran F Docherty, Adriaan A Voors, et al.
European Journal of Heart Failure|May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trialAdriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Journal of Cardiac Failure|July 4, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) TrialRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.
American Heart Journal|May 27, 2018
Leveraging electronic health records for clinical researchSudha R Raman, Lesley H Curtis, Robert Temple, et al.
Journal of Diabetes and Its Complications|May 2, 2025
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HFTariq Jamal Siddiqi, Yuxi Liu, Faiez Zannad, et al.
Journal of the American College of Cardiology|June 24, 2024
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF TrialsSubodh Verma, Javed Butler, Barry A Borlaug, et al.
Journal of Cardiac Failure|January 12, 2023
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker SubstudyChristopher R Defilippi, Wendimagegn G Alemayehu, Adriaan A Voors, et al.
Pageof 85

Showing results (661-670 of 842) with videos related to

Sort By:
Pageof 85
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
Journal of the American College of Cardiology|June 24, 2017
Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF TrialStephen J Greene, Adrian F Hernandez, Allison Dunning, et al.
Circulation. Heart Failure|September 15, 2016
Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure)Stephen J Greene, Adrian F Hernandez, Jie-Lena Sun, et al.
Circulation. Heart Failure|March 3, 2022
Developments in Exercise Capacity Assessment in Heart Failure Clinical Trials and the Rationale for the Design of METEORIC-HFGregory D Lewis, Kieran F Docherty, Adriaan A Voors, et al.
European Journal of Heart Failure|May 17, 2021
Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trialAdriaan A Voors, Hillary Mulder, Eugene Reyes, et al.
Journal of Cardiac Failure|July 4, 2021
Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) TrialRobert J Mentz, Hillary Mulder, Arend Mosterd, et al.
American Heart Journal|May 27, 2018
Leveraging electronic health records for clinical researchSudha R Raman, Lesley H Curtis, Robert Temple, et al.
Journal of Diabetes and Its Complications|May 2, 2025
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HFTariq Jamal Siddiqi, Yuxi Liu, Faiez Zannad, et al.
Journal of the American College of Cardiology|June 24, 2024
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF TrialsSubodh Verma, Javed Butler, Barry A Borlaug, et al.
Journal of Cardiac Failure|January 12, 2023
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker SubstudyChristopher R Defilippi, Wendimagegn G Alemayehu, Adriaan A Voors, et al.
Pageof 85